Clinical trial

Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers

NCT00343629 · Mayo Clinic, Other · Completed

Key facts

NCT number NCT00343629
Title Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers
Official title Bioequivalency Study of Sulindac in Capsule vs. Tablet Formulations
Lead sponsor Mayo Clinic, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Interventional
Conditions Unspecified Adult Solid Tumor, Protocol Specific
Intervention type Drug, Other
Interventions sulindac, pharmacological study
Enrollment 28
Start date Apr 1, 2006
Completion Oct 1, 2007
First posted Jun 23, 2006
Last update posted Apr 28, 2015
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies